Ureteral Stents Market Research, 2030
The global ureteral stents market was valued at $362.34 million in 2020, and is projected to reach $625.17 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030. Ureteral stent is a thin tube introduced into the ureter to prevent or treat blockage of the urine flow from the kidney. This procedure is employed to restore urine flow through blocked ureters and retain the normal functions of kidney. These devices are inserted during or after treating kidney stones or tumors and urinary incontinence. The ureteral stent removal takes place after treatment procedure. Kidney transplantation is often associated with vesicoureteral complications, stenosis, and obstruction of the ureter tube. Ureteral stents are used to decrease associated complications after renal transplantation, thus preventing urine leaks, ureteric stenosis, or obstruction. For instance, double-J ureteral stent successfully treats minor ureteric leaks and obstruction of transplant ureter.
The ureteral stents market size is expected to exhibit significant ureteral stents market growth during the forecast period, owing to increase in incidence of urological diseases caused by colonization of microorganisms or sedentary lifestyle. The key factors that drive the growth of ureteral stents market share are attributed to rise in number of kidney transplants, surge in geriatric population, and technological advancements in stents composition materials. However, lack of skilled professionals and adverse effects associated with the use of ureteral stents restrict the ureteral stents market opportunity. Conversely, advancements in healthcare infrastructure, rise in healthcare investment in developing countries, and development of ureteral stent tracker products are expected to provide numerous opportunities for the market growth during the forecast period.
The ureteral stents market is segmented on the basis of product type, application, material, end user, and region. According to product type, the market is divided into open end stents, double pigtail stents, closed end stents, and multiloop stents. On the basis of application, the market is divided into kidney stones, tumors, urinary incontinence, kidney transplantation, and others. On the basis of material, the market is divided into metallic stents and polymer stents. On the basis of end user, the market is divided into hospitals, clinics, and ambulatory surgical centers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Product Type Segment Review
By type, the ureteral stents market forecast is divided into open end stents, double pigtail stents, closed end stents, and multiloop stents. The double pigtail stents segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in urological disorders and urological obstruction, high demand of stents with minimized migration, and rise in awareness about advanced stents with less complications. In addition, numerous initiatives taken by government and healthcare agencies also boost the market growth. On the other side, the demand for multiloop stents is projected to exhibit the fastest market growth in the coming years, owing to advancement in the stent technology, high demand for polymer materials, such as Percuflex, and development of stents with soft, smooth, and flexible surface biocompatible stents, which is expected to drive the market growth of multiloop ureteral stents during the forecast period.
By Application Segment Review
By application, the ureteral stents market is classified into kidney stones, tumors, urinary incontinence, kidney transplantation, and others. The urinary incontinence segment presently dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to increase in geriatric population. In addition, the employment of ureteral stent, mainly double-J stent, ensures an appropriate urinary drainage from the kidney to the bladder.
By Material Segment Review
By material, the ureteral stents market is classified into metallic stents and polymer stents. The metallic stents segment presently dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to resistance of metallic ureteral stents to encrustation with stone material. This provides longer dwelling time and reduces the frequency of stent change surgeries. Moreover, the total benign ureteral obstruction procedural cost using metallic ureteral stent is less as compared to procedural cost using polymer stent.
By End User Segment Review
By end user, the ureteral stents market is classified into hospitals, clinics, and ambulatory surgical centers. The hospitals segment presently dominates the market, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to the preference of geriatric population for hospital treatments, as all associated treatments are performed under one roof. In addition, a greater number of surgical procedures are also performed in hospitals.
By Region Segment Review
By region, the ureteral stents industry is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend during the forecast period owing to presence of well-established healthcare systems and increase in prevalence of diseases, such as kidney stones and tumors. In addition, higher adoption rate for technologically advanced devices also boosts the market growth.
This report provides comprehensive competitive analysis and profiles of prominent market players, such as key players Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, C. R. Bard, Inc., Coloplast Ltd., Medline Industries, Inc., Allium Medical Solutions Ltd., Pnn Medical A/S, Teleflex Incorporated, and Olympus Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ureteral stents market analysis from 2020 to 2030 to identify the prevailing ureteral stents market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ureteral stents market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global ureteral stents market trends, key players, market segments, application areas, and market growth strategies.
Ureteral Stents Market Report Highlights
By Product Type
By End User
Key Market Players
Allium Medical Solutions Ltd., PNN MEDICAL A/S, OLYMPUS CORPORATION, TELEFLEX INCORPORATED, MEDLINE INDUSTRIES, INC., COLOPLAST A/S, COOK MEDICAL, INC., BOSTON SCIENTIFIC CORPORATION, B. BRAUN MELSUNGEN AG, C. R. BARD INC.
Ureteral stents are used for patients suffering with complex urological disorders, such as kidney stones and prostate cancer, which result in narrowing of the ureter or scarring on the wall of ureter. Different types of ureteral stents are used for opening the blocked ureters, thus allowing the urine flow. Increase in geriatric population, high prevalence of urological disorders due to sedentary lifestyle, and technological advancements in stent composition drive the growth of the ureteral stents market. North America accounts for the highest share owing to rise in demand for technologically innovative products and presence of better healthcare centres in the region. Asia-Pacific is expected to possess high market potential, owing to rise in prevalence of urological diseases, rise in government initiatives for the improvement of the healthcare sector, and increase in disposable incomes.